Hologic, Inc. Stock
Stocks
HOLX
US4364401012
Advanced Medical Equipment & Technology
|
Delayed
Nasdaq
16:00:00 2026-04-06 EDT
|
5-day change | 1st Jan Change | ||
| 76.01 USD | +0.48% |
|
-.--% | +2.04% |
| 07-30 | Quest Diagnostics And Hologic, Inc. Conduct National Health Trends Study On Bacterial Vaginosis And STI Co-Infection | CI |
| 06-30 | Hologic Recalls BioZorb Implantable Markers, FDA Says | MT |
| Market Cap | 16.97B 14.59B 13.73B 12.53B 23.43B 1,605B 23.51B 163B 62.91B 822B 63.72B 62.33B 2,618B | P/E 2024 |
24.3x | P/E 2025 | 27x |
|---|---|---|---|---|---|
| Enterprise Value | 17.39B 14.96B 14.07B 12.84B 24.01B 1,645B 24.09B 167B 64.47B 842B 65.31B 63.88B 2,683B | EV / Sales 2024 |
4.74x | EV / Sales 2025 | 3.75x |
| Free-Float |
73.08% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Hologic, Inc.
| 1 day | +0.48% | ||
| 6 months | +0.36% | ||
| Current year | +2.04% |
| Current year | 74.49 |  | 76.07 |
| 1 year | 63.19 | | 76.07 |
| 3 years | 51.9 | | 84.67 |
| 5 years | 51.9 | | 87.88 |
| 10 years | 26.49 | | 87.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 63 | 2026-04-06 |
Brian Montgomery
DFI | Director of Finance/CFO | - | 2026-04-15 |
Essex Mitchell
COO | Chief Operating Officer | 46 | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Joe Almeida
BRD | Director/Board Member | 63 | 2026-04-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/7/26 | Issuer sale | Director | 19,583 | 0.0088% | ||
| 4/7/26 | Issuer sale | General Counsel | 72,500 | 0.0325% | ||
| 4/7/26 | Issuer sale | Executive/Senior Manager | 123,246 | 0.0552% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.48% | -.--% | +13.86% | +4.21% | 16.97B | |
| -1.26% | -0.54% | +24.60% | +15.45% | 227B | |
| -1.26% | -2.76% | +3.72% | -18.54% | 146B | |
| -2.52% | -2.70% | -21.45% | +23.38% | 130B | |
| -2.05% | -1.04% | -55.42% | -11.30% | 69.27B | |
| -2.63% | -0.94% | +11.07% | +18.15% | 51.82B | |
| +0.43% | -0.92% | -18.09% | -12.83% | 49.99B | |
| -2.37% | -1.76% | +17.17% | +29.76% | 42.53B | |
| -1.39% | -1.27% | +33.64% | +51.45% | 40.22B | |
| -2.12% | +2.15% | +120.58% | +37.37% | 32.95B | |
| Average | -1.57% | -0.78% | +12.97% | +13.71% | 80.62B | |
| Weighted average by Cap. | -1.70% | -1.37% | +6.78% | +9.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.03B 3.47B 3.26B 2.98B 5.57B 381B 5.58B 38.65B 14.94B 195B 15.14B 14.8B 622B | 4.1B 3.53B 3.32B 3.03B 5.66B 388B 5.68B 39.33B 15.2B 199B 15.4B 15.06B 633B |
| Net income | 790M 679M 639M 583M 1.09B 74.67B 1.09B 7.57B 2.93B 38.24B 2.96B 2.9B 122B | 566M 487M 458M 418M 781M 53.5B 784M 5.43B 2.1B 27.4B 2.12B 2.08B 87.27B |
| Net Debt | 321M 276M 260M 237M 444M 30.39B 445M 3.08B 1.19B 15.56B 1.21B 1.18B 49.57B | 421M 362M 340M 311M 581M 39.81B 583M 4.04B 1.56B 20.38B 1.58B 1.55B 64.93B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- HOLX Stock
Select your edition
All financial news and data tailored to specific country editions
